SE7510988L - Nya farmaceutiskt aktiva foreningar - Google Patents

Nya farmaceutiskt aktiva foreningar

Info

Publication number
SE7510988L
SE7510988L SE7510988A SE7510988A SE7510988L SE 7510988 L SE7510988 L SE 7510988L SE 7510988 A SE7510988 A SE 7510988A SE 7510988 A SE7510988 A SE 7510988A SE 7510988 L SE7510988 L SE 7510988L
Authority
SE
Sweden
Prior art keywords
pharmaceutical active
new pharmaceutical
active associations
associations
new
Prior art date
Application number
SE7510988A
Other languages
English (en)
Swedish (sv)
Inventor
L A Svensson
L M Sorenby
K I L Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE7510988A priority Critical patent/SE7510988L/xx
Priority to ZA765331A priority patent/ZA765331B/xx
Priority to DE19762640972 priority patent/DE2640972A1/de
Priority to AT682376A priority patent/AT347427B/de
Priority to FI762660A priority patent/FI762660A7/fi
Priority to SU762402852A priority patent/SU638252A3/ru
Priority to NZ182165A priority patent/NZ182165A/xx
Priority to AU18122/76A priority patent/AU503212B2/en
Priority to DD195022A priority patent/DD126278A5/xx
Priority to LU75916A priority patent/LU75916A1/xx
Priority to FR7629467A priority patent/FR2326183A1/fr
Priority to NO763345A priority patent/NO763345L/no
Priority to DK439776AA priority patent/DK141622B/da
Priority to ES451979A priority patent/ES451979A1/es
Priority to NL7610845A priority patent/NL7610845A/xx
Priority to GB7640684A priority patent/GB1542317A/en
Priority to JP51118924A priority patent/JPS5242840A/ja
Priority to CS766357A priority patent/CS199643B2/cs
Priority to CS782253A priority patent/CS199644B2/cs
Priority to BE171148A priority patent/BE846837A/xx
Publication of SE7510988L publication Critical patent/SE7510988L/xx
Priority to SU772532454A priority patent/SU674669A3/ru
Priority to AT108278A priority patent/AT350526B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7510988A 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar SE7510988L (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar
ZA765331A ZA765331B (en) 1975-10-01 1976-09-07 Novel pharmaceutically active compounds
DE19762640972 DE2640972A1 (de) 1975-10-01 1976-09-11 Aminoaethanolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT682376A AT347427B (de) 1975-10-01 1976-09-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen-(1) und deren pharmazeutisch akzeptablen salzen
FI762660A FI762660A7 (enrdf_load_stackoverflow) 1975-10-01 1976-09-16
SU762402852A SU638252A3 (ru) 1975-10-01 1976-09-22 Способ получени производных аминоэтанола или их солей
NZ182165A NZ182165A (en) 1975-10-01 1976-09-27 Derivatives of 1-(3,5-dihydroxyphenyl)-2 aminoethanol, andpharmaceutical composition
AU18122/76A AU503212B2 (en) 1975-10-01 1976-09-27 1-(3,5-dihydroxyphenyl)-2[hydroxyalkyl)amino] ethanols and their esters
DD195022A DD126278A5 (enrdf_load_stackoverflow) 1975-10-01 1976-09-28
NO763345A NO763345L (enrdf_load_stackoverflow) 1975-10-01 1976-09-30
FR7629467A FR2326183A1 (fr) 1975-10-01 1976-09-30 Composes et compositions a activite antiallergique et antianaphylactique
LU75916A LU75916A1 (enrdf_load_stackoverflow) 1975-10-01 1976-09-30
DK439776AA DK141622B (da) 1975-10-01 1976-09-30 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-(3,5-dihydroxyfenyl)-2-aminoætanolderivater eller syreadditionssalte deraf.
ES451979A ES451979A1 (es) 1975-10-01 1976-09-30 Un metodo de preparacion de compuestos antialergicos.
NL7610845A NL7610845A (nl) 1975-10-01 1976-09-30 Nieuwe farmacologisch werkzame verbindingen.
GB7640684A GB1542317A (en) 1975-10-01 1976-09-30 Phenylethanolamine derivatives
JP51118924A JPS5242840A (en) 1975-10-01 1976-10-01 Novel pharmaceutically active compound
CS766357A CS199643B2 (en) 1975-10-01 1976-10-01 Method of producing novel derivatives of phenylaminoethanol
CS782253A CS199644B2 (en) 1975-10-01 1976-10-01 Method of producing new derivatives of phenylaminoethanol
BE171148A BE846837A (fr) 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique,
SU772532454A SU674669A3 (ru) 1975-10-01 1977-10-13 Способ получени производных этанола или их солей
AT108278A AT350526B (de) 1975-10-01 1978-02-15 Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen -(1) und von deren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
SE7510988L true SE7510988L (sv) 1977-04-02

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Country Status (19)

Country Link
JP (1) JPS5242840A (enrdf_load_stackoverflow)
AT (1) AT347427B (enrdf_load_stackoverflow)
AU (1) AU503212B2 (enrdf_load_stackoverflow)
BE (1) BE846837A (enrdf_load_stackoverflow)
CS (2) CS199643B2 (enrdf_load_stackoverflow)
DD (1) DD126278A5 (enrdf_load_stackoverflow)
DE (1) DE2640972A1 (enrdf_load_stackoverflow)
DK (1) DK141622B (enrdf_load_stackoverflow)
ES (1) ES451979A1 (enrdf_load_stackoverflow)
FI (1) FI762660A7 (enrdf_load_stackoverflow)
FR (1) FR2326183A1 (enrdf_load_stackoverflow)
GB (1) GB1542317A (enrdf_load_stackoverflow)
LU (1) LU75916A1 (enrdf_load_stackoverflow)
NL (1) NL7610845A (enrdf_load_stackoverflow)
NO (1) NO763345L (enrdf_load_stackoverflow)
NZ (1) NZ182165A (enrdf_load_stackoverflow)
SE (1) SE7510988L (enrdf_load_stackoverflow)
SU (2) SU638252A3 (enrdf_load_stackoverflow)
ZA (1) ZA765331B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
HU224814B1 (en) * 1995-12-28 2006-02-28 Mitsubishi Pharma Corp Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
DK2332921T3 (en) 2003-06-17 2016-05-09 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3benzazepine hydrochloride
SG10201508066VA (en) 2006-04-03 2015-10-29 Arena Pharm Inc Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
ES2522587T3 (es) 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
EP2288585A1 (en) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
SG188364A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Salts of lorcaserin with optically active acids
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
US20130315994A1 (en) 2010-09-01 2013-11-28 Zezhi Jesse Shao Modified-release dosage forms of 5-ht2c agonists useful for weight management
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела

Also Published As

Publication number Publication date
AU503212B2 (en) 1979-08-30
JPS5242840A (en) 1977-04-04
NO763345L (enrdf_load_stackoverflow) 1977-04-04
AU1812276A (en) 1978-04-06
SU674669A3 (ru) 1979-07-15
DK439776A (enrdf_load_stackoverflow) 1977-04-02
NL7610845A (nl) 1977-04-05
ES451979A1 (es) 1978-01-01
CS199643B2 (en) 1980-07-31
ZA765331B (en) 1977-08-31
SU638252A3 (ru) 1978-12-15
LU75916A1 (enrdf_load_stackoverflow) 1978-05-16
ATA682376A (de) 1978-05-15
GB1542317A (en) 1979-03-14
DD126278A5 (enrdf_load_stackoverflow) 1977-07-06
BE846837A (fr) 1977-04-01
CS199644B2 (en) 1980-07-31
DK141622B (da) 1980-05-12
FR2326183A1 (fr) 1977-04-29
DE2640972A1 (de) 1977-04-14
FI762660A7 (enrdf_load_stackoverflow) 1977-04-02
AT347427B (de) 1978-12-27
NZ182165A (en) 1978-07-10

Similar Documents

Publication Publication Date Title
SE7605620L (sv) Farmakologiskt aktiva foreningar
SE7612366L (sv) Nya hydroxibensylmalonsyra-derivat.
SE7604761L (sv) Nya polypeptider
SE7710762L (sv) Farmakologiskt aktiva foreningar
SE7600139L (sv) Nya vifenyloxiderivat
SE7510988L (sv) Nya farmaceutiskt aktiva foreningar
SE408266B (sv) Narkosmedelavdunstare
SE7506947L (sv) Farmakologiskt aktiva foreningar
FI56525B (fi) Nya kromogena trombinsubstrat
SE7608478L (sv) Farmaceutica
SE7702771L (sv) Farmakologiskt aktiva foreningar
FI773812A7 (fi) Farmaceutiska foereningar
FR2326189A2 (fr) Composition pharmaceutique
SE7703948L (sv) Nya anibakteriella foreningar
SE7603563L (sv) Nya tiazolinoner
SE7606877L (sv) Nya organiska foreningar, deras framstellning och anvendning
FI773813A7 (fi) Farmaceutiska foereningar
SE7605158L (sv) Nya organiska foreningar
SE7705857L (sv) Farmaceutiskt aktiva foreningar
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar
SE7605818L (sv) Nya diureidforeningar
BE840608A (fr) Nouvelles compositions pharmaceutiques
SE7606405L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7506348L (sv) Hjertaktiva foreningar
SE7600480L (sv) Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk